SHA:688336 Revenue

Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 311.12M CNY in the quarter ending March 31, 2025, with 16.57% growth. This brings the company's revenue in the last twelve months to 1.24B, up 15.29% year-over-year. In the year 2024, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 1.19B with 17.70% growth.

Revenue (ttm)

1.24B

Revenue Growth

+15.29%

P/S Ratio

28.68

Revenue / Employee

1.24M

Employees

995

Market Cap

35.50B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.19B	179.53M	17.70%
Dec 31, 2023	1.01B	188.54M	22.84%
Dec 31, 2022	825.49M	-103.32M	-11.12%
Dec 31, 2021	928.81M	273.80M	41.80%
Dec 31, 2020	655.01M	-522.39M	-44.37%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Sichuan Biokin Pharmaceutical	5.82B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings